PROVIDER PROFILE · NPI 1033175658
Kien-An DuongMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
487
Unique beneficiaries
—
Total services
820
Distinct HCPCS
9
Medicare payment
$33K
Peer benchmark
Total Medicare services vs. 10,499 Internal Medicine providers in CA — top quintile (cohort median 531).
PRESCRIBING · PART D · 2024
Total Rx claims
8,262
Beneficiaries
—
Total drug cost
$812K
Distinct drugs
132
Brand share
19.8%
Top prescribed drugs
Atorvastatin Calcium832 claims
Losartan Potassium545 claims
Amlodipine Besylate354 claims
Tamsulosin Hcl339 claims
Metformin Hcl337 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$395
Payment records
7
By payment type
Food and Beverage$395
Top paying entities
Food and Beverage$395
REFERRAL NETWORK
Where Kien-An Duong's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 6 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Unilab Corporation Clinical Laboratory · West Hills, CA | 74 | 265 |
| ORANGE COAST MEMORIAL MEDICAL CENTER | 30 | 65 |
| Arfa Babaknia Family Practice · Fountain Valley, CA | 22 | 78 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Unilab Corporation Clinical Laboratory · West Hills, CA | 71 | 267 |
| ORANGE COAST MEMORIAL MEDICAL CENTER | 51 | 100 |
| Arfa Babaknia Family Practice · Fountain Valley, CA | 16 | 59 |
| SZYMANOWSKI, JEREMY | 12 | 25 |
| CHEUNG, NAOMI | 11 | 46 |
| HANNA, NANCY | 11 | 39 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE